Xuping Xi

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Li Zhang, Yan Huang, Shaodong Hong et al. · The Lancet · 2016 · 515 citations

Cisplatin Versus Fluorouracil, Medicine, Metronomic Therapy +6

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study

Shaodong Hong, Yaxiong Zhang, Gengsheng Yu et al. · Journal of Clinical Oncology · 2021 · 95 citations · Full text

PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma

Feng Liu, Xuping Xi, Hui Wang et al. · Radiation Oncology · 2017 · 40 citations · Full text

Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy

Baomin Zheng, Xiaodong Zhu, Mengzhong Liu et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 31 citations

Moxibustion, Medicine, Shuanghua Baihe Tablets +7

ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma

Hekun Jin, Xiaoxue Xie, Hui Wang et al. · PLoS ONE · 2014 · 23 citations · Full text